The post ZEC Short Near Average Price as Largest ZEC Short on Hyperliquid Reaches $14.1M Position appeared on BitcoinEthereumNews.com. COINOTAG News notes, per HyperInsight, that the ZEC short on Hyperliquid nears its average entry as buyers push spot higher. In the last hour, the address added roughly $1.72 million to its ZEC short exposure, lifting total to $14.1 million. Unrealized P&L has narrowed from > $3.3 million to about $0.3 million, with the entry set near $412. Wallet previously initiated a ZEC short on October 10 near $184, then added to flatten it, lifting the average to $419. Floating loss peaked at $21 million on October 17. Current posture includes shorts on ETH, ZEC, MON, and HYPE, with ETH leading gains and unrealized profit around $6.22 million (194%), on a book near $48.05 million at $4,014. MON short opened with $5.72 million notional on 3x leverage, yielding $2.26 million unrealized profit (118%). This is the largest MON short on Hyperliquid in this session, signaling capital rotation across alt-coin clusters. Source: https://en.coinotag.com/breakingnews/zec-short-near-average-price-as-largest-zec-short-on-hyperliquid-reaches-14-1m-positionThe post ZEC Short Near Average Price as Largest ZEC Short on Hyperliquid Reaches $14.1M Position appeared on BitcoinEthereumNews.com. COINOTAG News notes, per HyperInsight, that the ZEC short on Hyperliquid nears its average entry as buyers push spot higher. In the last hour, the address added roughly $1.72 million to its ZEC short exposure, lifting total to $14.1 million. Unrealized P&L has narrowed from > $3.3 million to about $0.3 million, with the entry set near $412. Wallet previously initiated a ZEC short on October 10 near $184, then added to flatten it, lifting the average to $419. Floating loss peaked at $21 million on October 17. Current posture includes shorts on ETH, ZEC, MON, and HYPE, with ETH leading gains and unrealized profit around $6.22 million (194%), on a book near $48.05 million at $4,014. MON short opened with $5.72 million notional on 3x leverage, yielding $2.26 million unrealized profit (118%). This is the largest MON short on Hyperliquid in this session, signaling capital rotation across alt-coin clusters. Source: https://en.coinotag.com/breakingnews/zec-short-near-average-price-as-largest-zec-short-on-hyperliquid-reaches-14-1m-position

ZEC Short Near Average Price as Largest ZEC Short on Hyperliquid Reaches $14.1M Position

2025/12/05 16:18

COINOTAG News notes, per HyperInsight, that the ZEC short on Hyperliquid nears its average entry as buyers push spot higher. In the last hour, the address added roughly $1.72 million to its ZEC short exposure, lifting total to $14.1 million. Unrealized P&L has narrowed from > $3.3 million to about $0.3 million, with the entry set near $412.

Wallet previously initiated a ZEC short on October 10 near $184, then added to flatten it, lifting the average to $419. Floating loss peaked at $21 million on October 17. Current posture includes shorts on ETH, ZEC, MON, and HYPE, with ETH leading gains and unrealized profit around $6.22 million (194%), on a book near $48.05 million at $4,014.

MON short opened with $5.72 million notional on 3x leverage, yielding $2.26 million unrealized profit (118%). This is the largest MON short on Hyperliquid in this session, signaling capital rotation across alt-coin clusters.

Source: https://en.coinotag.com/breakingnews/zec-short-near-average-price-as-largest-zec-short-on-hyperliquid-reaches-14-1m-position

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.